Abstract
Introduction
A low-energy neutron generator was proposed's2 a few years ago based on a proton RFQ3 linac. The RFQ would deliver a high-current proton beam at 2.5 MeV to a thick "Li target to produce neutrons from the well known 'Li(p,n)"Be reaction.
When combined with a compact neutron moderator, a 10-mA proton beam current could produce a thermal neutron flux of 2 X 10" n/cm2s. Although the earlier proposal emphasized the thermal neutron flux, an RFQbased epithermal neutron source can be designed from this same neutron generatof6 for treatment of brain tumors by BNCT.
In BNCT, a patient is administered a tumor-specific 'OB-enriched compound and is then irradiated with epithermal neutrons. If the ' OB attaches to or is incorporated into tumor cells with high specificity and concentration, but is in low concentration in the blood a t the time of irradiation, then the 'OB(n, &Li reaction products create a radiation dose that is highly localized to the tumor. S t u d i e P confirm the potential of a low-energy proton facility to generate epithermal neutrons with an acceptable energy spectrum and intensity. Monte Carlo studies show that a 10-mA proton beam can produce a useful neutron flux of 5.0 X lo8 neutrondun2s. For a single irradiation session of 20 Cy (100 rad) to the tumor, a treatment time of 1.5 hours is necessary. To reduce the patient's irradiation time, it is desirable to increase the beam current. Beam currents of more than 40 mA have been accelerated in an RFQ operating at 100% duty factor.' However, as the beam current increases, the capital and operating costs of the radio-frequency power for the accelerator increase, and beam-heat removal from the liquid lithium target becomes more difficult. Ultimately, the choice of beam current will be determined by the tradeoff between cost and treatment time.
Accelerator Conceptual Design
We present a conceptual design of an RFQ-based 2.5-MeV, high-current proton accelerator for BNCT. Spacecharge effects in the RFQ govern the maximum permissible beam currents. Although we believe beam currents of 1 O O m A and higher are practical for 100% duty factor, we including the accelerator system, a vapor-cooled liquid lithium target, the neutron moderator assembly, and a patient undergoing treatment. A block diagram of the accelerator system is shown in Fig. 2 , consisting of an ion source, the low-energy beam transport (LEBT), an RFQ linac, a high-energy beam transport (HEBT) system, and the radio-frequency power system for the RFQ. An ion source with cusped-field confinement and with single-gap extraction would provide reliable performance at 30 kV with 35-mA extracted H+ beam current. The LEBT would consist of a two-lens, magnetic solenoid focusing channel in a point-to-paralleUparalle1-to-point configuration. This LEBT design has sufficient flexibility to match a wide range of extracted beams into the RFQ acceptance. Based on initial design calculations, the solenoids would operate a t about 0.5T, and the LEBT length would be approximately 0.5 m. An RFQ has been designed using the codes and procedures developed a t Los Alamos with the objective of providing high transmission and high beam quality, while keeping both the electrical and physical lengths short and the power requirement low. The major engineering challenge for cw accelerators is the removal of heat generated by rf power dissipation on the cavity walls and the prevention of temperature changes that detune the cavity. We have produced an unoptimized design example for the RFQ, and have simulated the performance, including space charge, using the program PARMTEQ. The design and performance parameters are shown in TableI.
F-l SYSTEM
The calculated beam profile plots for displacement x, and phase and energy relative to the synchronous particle are shown in Fig. 3 . Initial and final phase-space distributions are shown in Fig. 4 . The HEBT design has not yet been investigated, but we believe this should be a relatively straightforward design to transport the beam from the RFQ and to distribute it uniformly on the lithium target.
The control and instrumentation requirements for the accelerator should also be straightforward.
Target and Moderator Conceptual Design
A moderator assembly is shown in Fig. 5 . The moderator assembly has been designed to make the gammaray dose as low as possible and yet transmit to the patient a large fraction of the source neutrons, degraded in energy to between 1 eV and 10 keV. The forward-directed neutrons are moderated by beryllium oxide (BeO), and control of the average energy of the neutrons emerging from the moderator assembly is achieved by adjusting the thickness of the BeO. It is anticipated that when treating deep-seated tumors, more energetic neutrons will be required than for superficial tumors. The forward-directed neutrons are the most energetic and require the higher moderating power of BeO; whereas the neutrons born at wider angles are less energetic and require less moderation and more reflection by the alumina that they encounter.
We have evaluated the performance of the moderator assembly, which is illustrated in Fig. 5 . The moderator assembly consists of a cylindrical moderator of BeO, which is 25 cm in diameter and 20 cm in height, surrounded by a 30-cm-thick alumina reflector. A loading of 0.05 glcm2 of 6Li is placed a t the interface between the moderator and reflector regions, to reduce the gamma-ray dose arising from the 2'Al(n, y)28A1 reaction. Also, a loading of 0.01 glcm2 of 6Li is placed a t the window of the irradiation port to reduce the thermal neutron contamination. In addition, a 10-cm-thick layer of D 0, which is in turn surrounded by an outer skin of 6LiF, fungons as a neutron shield to reduce the patient's whole-body dose. The escaping neutrons are thermalized by the D 0 and are then captured by 6Li. Conventional neutron shiedng, such as borated polyethylene, is not appropriate for our moderator assembly because both hydrogen and boron produce secondary gamma rays by capturing thermal neutrons.
The geometrical model of our moderator assembly contains a neutron source that is uniformly distributed over a 10-cm2 area on the top surface of the inner (BeO) cylinder on the cylinder's centerline. The neutron source has the distribution in energy and angle that is produced by a beam of 2.5-MeV protons traveling parallel to the moderator assembly central axis. The model also contains a 10-cm radius spherical phantom head (C,H,,OI8N) located on the moderator assembly central axis with its center 15 cm from the assembly base. Our analysis models two distinct processes: (1) neutron generation in the 7Li target, and (2) neutron and gamma-ray transport in the moderator assembly and head phantom.
Neutron generation in the 7Li target was calculated by simulating the production of neutrons, as protons slow down in the target, using the doubly differential cross-section for the 7Li(p, d7Be reactione and the stopping power for protons in l i t h i~m .~ Neutron transport in the moderator assembly was calculated using the Monte Carlo code MORSE.l0 For the moderator assembly in Fig. 5 with a 3 0 -4 proton beam producing 2.1 X 1013 ds, the useful neutron flux (i.e., the flux with neutron energy > 1 eV) evaluated a t the irradiation point is 1.5 X lo9 n/cm2-s. The corresponding absorbed dose rates for neutrons and gamma rays are 5.7 and 1.9 cGylmin, respectively. The ratio of the neutron absorbed dose rate to the useful neutron flux is 6.5 X lo-" cGy/n-cm-2, which is slightly higher than, but comparable to, the value of the ratio that has been estimated for a proposed reactor beam."
Generally speaking, for the neutrons produced by our conceptual neutron irradiation facility, the ratio of the entrance absorbed dose to the peak absorbed dose for normal tissue is larger than for an ideal 2-keV reactor neutron beam. The maximum absorbed dose to a tumor6 is 4.88 X cGy1source neutron for a loB concentration of 30 pglg tumor. Therefore, for a 30-mA beam and 2.1 X 1013 ds, the maximum absorbed dose rate is 1.02cGyIs. For a singlesession irradiation of 20 Cy to the tumor, the treatment time is about 33 min. This treatment time is quite reasonable, and could be reduced to about 11 min. with a 100 mA RFQ.
